Adjuvant Partners is a commercial strategy and business development consulting firm focused on biotech, pharmaceutical and medical device markets. Essentially, our clients are established and emerging companies driven to achieve key business imperatives. Whether these imperatives are related to product development, portfolio expansion, licensing, market development or growth through acquisition, we assist our clients in creating the process and relationships to achieve these outcomes faster.

Drug development is a collaborative process involving input and unique contributions from numerous talented scientists, technicians, and strategists throughout the development process. Indeed, within the last 10 years the pharmaceutical, biotech, and device industries have come to appreciate that it is virtually impossible for any firm to retain the necessary expertise in all facets of product development to meet their productivity goals alone. Through partnerships companies extend their pipelines, access new market opportunities, improve clinical and regulatory prospects, and enhance in-house programs. These activities are essential to maximizing commercialization opportunities and driving shareholder value. Partnerships and outsourcing are now a hallmark of the industry and most industry experts expect the steady growth in collaborations and dealmaking to continue for the foreseeable future.

It is this essential activity of every drug and device company that is the focus of our work. We have dedicated our careers to understanding and perfecting the partnering process. In doing so, we have built an industry network that is second to none and strategic, proprietary search and evaluation tools that are designed to support the work of business development professionals in all sectors of the industry. We use these tools and expertise to provide sound strategic, financial, and operational advisory services to a range of customers from small, emerging companies to established multinational pharma and device companies. Our mission is to deliver specialized knowledge to optimize the business development and strategic transaction process to accelerate value creation for our clients. There is no mass market in transaction advisory services - we sustain our business through trusted relationships and performance, one client and one engagement at a time.

We invite you to learn how Adjuvant Partners can improve your business. We strive to maximize opportunity and value for our clients and their shareholders. Contact us by emailing Morrie Ruffin at mruffin@adjuvant.com or by calling us at (301) 761-4522.





Adjuvant Representative Clients

Advinus Therapeutics
Aeolus Pharmaceuticals
Alcavis HDC
Alliance for Regenerative Medicine
Astellas Pharmaceuticals
AstraZeneca
Axeuron Therapeutics
Bioinformatics
BioStrategies LC
C2N Diagnostics
Cellular Dynamics International
Cell Therapeutics
Code-N
Compugen
CryoBioPhysica
DrugMode
EBD Group
Enlivex
Innovative Biologics
Integra Ventures
Kauffman Foundation
King Pharmaceuticals
MC2 Biotek
MDRNA
Moksha8
MS Society / Fast Forward
Numerate
RhinoCyte
Sanofi-Aventis
Santhera Pharmaceuticals
Southern Lights Biomaterials
Tissue Genesis
Wake Forest University

      Privacy Policy

© Adjuvant Partners, LLC 2012. All rights reserved.